+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Imaging System Market - Global Forecast 2026-2032- Product Image
Cancer Imaging System Market - Global Forecast 2026-2032- Product Image
New

Cancer Imaging System Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6014726
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cancer imaging systems are redefining oncology care, enabling integrated diagnostics, enhanced clinical workflows, and actionable analytics that directly inform decision-making for healthcare leaders. Senior decision-makers navigating transformation in this sector require an authoritative view on evolving commercial and technological strategies shaping tomorrow’s oncology imaging landscape.

Market Snapshot: Cancer Imaging System Market Size and Growth

The Cancer Imaging System Market is experiencing steady growth, expanding from USD 19.24 billion in 2025 to USD 20.07 billion in 2026 and projected to reach USD 28.45 billion by 2032. The compound annual growth rate (CAGR) stands at 5.74%. This sustained expansion is underpinned by hospitals, diagnostic centers, and research institutions seeking to enhance detection, therapy planning, and disease monitoring capabilities.

Cancer Imaging System Market Scope & Strategic Segmentation

Market intelligence on cancer imaging systems covers a breadth of product types, deployed technologies, core clinical applications, and user environments. Major segmentation points include:

  • Modalities: Computed tomography (including multi-slice, dual source, cone beam), digital radiography (flat panel detector, charged coupled device), magnetic resonance imaging (closed, open, and extremity systems), ultrasound (2D, 3D/4D, Doppler), positron emission tomography (PET-CT, PET-MRI combinations).
  • Clinical Applications: Breast, colorectal, lung, and prostate oncology pathways drive unique requirements for screening, diagnosis, staging, and longitudinal monitoring. Modalities align with anatomical, functional, and molecular characterization needs through all phases of care.
  • Enabling Technologies: Artificial intelligence (AI) tools for detection, diagnosis, and workflow management, contrast agents improving imaging clarity, hybrid imaging architectures, and advanced 3D visualization supporting surgical planning and multidisciplinary review.
  • End User Environments: Academic research institutes, hospitals, diagnostic imaging centers, and outpatient clinics—each with specific procurement and throughput priorities.
  • Regions: Americas, Europe, Middle East and Africa, and Asia-Pacific, reflecting differentiated adoption rates, regulatory landscapes, and investment strategies.

Key Takeaways for Senior Decision-Makers

  • AI and advanced software are now embedded within clinical imaging workflows, delivering reproducible results and workflow optimization.
  • Hybrid imaging advances reduce diagnostic uncertainty and refine clinical pathways, supporting improved treatment decisions.
  • Market migration toward outpatient and ambulatory deployments is increasing, aided by portable equipment and digital solutions.
  • Vendors are shifting commercial models toward integrated hardware, software, and managed service contracts, supporting total cost of ownership goals.
  • Collaboration between clinicians, manufacturers, and policy stakeholders is essential as regulatory and reimbursement frameworks focus more on clinical utility and outcomes.
  • Regional dynamics require tailored commercialization, regulatory, and supply chain strategies, creating both opportunity and complexity in global expansion.

Impact of 2025 Tariff Adjustments

United States tariffs introduced in 2025 have changed procurement economics for imaging hardware and components. Health systems have increased focus on equipment lifecycle extension, robust service arrangements, and consideration of alternative sourcing to lower risk. Vendors are developing outcome-linked pricing, integrated financing, and managed equipment service models to address capital constraints and mitigate exposure to future trade policy changes. Software and cloud-based services are emerging as strategic differentiators due to their lesser sensitivity to tariffs and ability to add clinical value without incurring additional import costs.

Competitive Landscape: Cancer Imaging System Market

Competition is shifting decisively toward integrated platforms and cloud-enabled service ecosystems. Companies invest in analytics, connectivity, and clinical evidence to differentiate offerings and secure customer retention. Strategic alliances and M&A activity are expanding portfolio breadth and AI capabilities, while localized service and training provisions influence long-term adoption. Regulatory readiness and health economics underpin success in procurement negotiations and payer coverage recognition.

Methodology & Data Sources

This report’s insights derive from a mixed-methods approach combining structured expert interviews with radiologists, procurement officers, and technologists, plus technical review of peer-reviewed clinical literature, regulatory filings, and public product data. Analytical methods included scenario analysis across procurement models, regulatory sensitivity, and end-user needs, with findings validated iteratively by clinical and market experts for reliability.

Why This Report Matters for Healthcare Leaders

  • Presents a granular analysis of shifting oncology imaging economics, technology integration, and commercial strategy for pragmatic decision-making.
  • Enables benchmarking across clinical, regional, and operational dimensions crucial to multisite health systems and investors.
  • Unpacks how emerging market and trade forces drive changes in adoption, competitive differentiation, and strategic planning priorities.

Conclusion

Advanced oncology imaging now anchors precision care and long-term value in healthcare. Senior leaders equipped with robust insights and actionable strategies will be positioned to maximize clinical and operational impact in a dynamic global market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cancer Imaging System Market, by Product Type
8.1. Computed Tomography
8.1.1. Cone Beam Computed Tomography
8.1.2. Dual Source Computed Tomography
8.1.3. Multi Slice Computed Tomography
8.2. Digital Radiography
8.2.1. Charged Coupled Device
8.2.2. Flat Panel Detector
8.3. Magnetic Resonance Imaging
8.3.1. Closed Magnetic Resonance Imaging
8.3.2. Extremity Magnetic Resonance Imaging
8.3.3. Open Magnetic Resonance Imaging
8.4. Positron Emission Tomography
8.4.1. PET CT
8.4.2. PET MRI
8.5. Ultrasound
8.5.1. Doppler Analysis
8.5.2. Three D Four D Analysis
8.5.3. Two D Analysis
9. Cancer Imaging System Market, by Application
9.1. Breast Cancer
9.2. Colorectal Cancer
9.3. Lung Cancer
9.4. Prostate Cancer
10. Cancer Imaging System Market, by Technology
10.1. Artificial Intelligence
10.1.1. Computer Aided Detection
10.1.2. Computer Aided Diagnosis
10.1.3. Workflow Management
10.2. Contrast Imaging
10.2.1. CT Contrast Agents
10.2.2. MRI Contrast Agents
10.2.3. Ultrasound Contrast Agents
10.3. Hybrid Imaging
10.3.1. PET CT Hybrid
10.3.2. PET MRI Hybrid
10.3.3. SPECT CT Hybrid
10.4. Three D Visualization
10.4.1. Max Intensity Projection
10.4.2. Surface Rendering
10.4.3. Volume Rendering
11. Cancer Imaging System Market, by End User
11.1. Academic Research Institutes
11.2. Clinics
11.3. Diagnostic Imaging Centers
11.4. Hospitals
12. Cancer Imaging System Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Cancer Imaging System Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Cancer Imaging System Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Cancer Imaging System Market
16. China Cancer Imaging System Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Agfa-Gevaert N.V.
17.6. Agilent Technologies Inc.
17.7. Analogic Corporation
17.8. Barco NV
17.9. Becton, Dickinson and Company
17.10. Bio-Rad Laboratories Inc.
17.11. Bracco Imaging S.p.A.
17.12. Canon Medical Systems Corporation
17.13. Carestream Health Inc.
17.14. Danaher Corporation
17.15. Delphinus Medical Technologies Inc.
17.16. Elekta AB
17.17. Esaote S.p.A.
17.18. F. Hoffmann-La Roche Ltd.
17.19. FUJIFILM Holdings Corporation
17.20. GE HealthCare Technologies Inc.
17.21. Hitachi, Ltd.
17.22. Hologic Inc.
17.23. IBA Ion Beam Applications SA
17.24. Illumina Inc.
17.25. Konica Minolta Inc.
17.26. Koninklijke Philips N.V.
17.27. Lantheus Holdings Inc.
17.28. Samsung Medison Co., Ltd.
17.29. Siemens Healthineers AG
List of Figures
FIGURE 1. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CANCER IMAGING SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CANCER IMAGING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA CANCER IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DUAL SOURCE COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DUAL SOURCE COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DUAL SOURCE COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MULTI SLICE COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MULTI SLICE COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MULTI SLICE COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CHARGED COUPLED DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CHARGED COUPLED DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CHARGED COUPLED DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY FLAT PANEL DETECTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY FLAT PANEL DETECTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY FLAT PANEL DETECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CLOSED MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CLOSED MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CLOSED MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY EXTREMITY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY EXTREMITY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY EXTREMITY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY OPEN MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY OPEN MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY OPEN MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET CT, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET CT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET CT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET MRI, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET MRI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET MRI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DOPPLER ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DOPPLER ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DOPPLER ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D FOUR D ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D FOUR D ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D FOUR D ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY TWO D ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY TWO D ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY TWO D ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTER AIDED DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTER AIDED DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTER AIDED DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTER AIDED DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTER AIDED DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTER AIDED DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY WORKFLOW MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY WORKFLOW MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY WORKFLOW MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CT CONTRAST AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CT CONTRAST AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CT CONTRAST AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MRI CONTRAST AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MRI CONTRAST AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MRI CONTRAST AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND CONTRAST AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND CONTRAST AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND CONTRAST AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET CT HYBRID, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET CT HYBRID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET CT HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET MRI HYBRID, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET MRI HYBRID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET MRI HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SPECT CT HYBRID, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SPECT CT HYBRID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SPECT CT HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAX INTENSITY PROJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAX INTENSITY PROJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAX INTENSITY PROJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SURFACE RENDERING, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SURFACE RENDERING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SURFACE RENDERING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY VOLUME RENDERING, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY VOLUME RENDERING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY VOLUME RENDERING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 201. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 202. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 203. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 204. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 205. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 207. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 208. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 209. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 210. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 211. EUROPE CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 229. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 230. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 231. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 232. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 233. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 235. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 236. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 237. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 238. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 239. AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 248. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 255. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 257. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 258. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 259. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 260. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 261. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 262. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 263. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 264. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 265. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 266. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 267. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 268. ASEAN CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 270. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 271. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 272. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 273. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 274. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 275. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 276. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 277. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 278. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 279. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 280. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 281. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 282. GCC CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 297. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 298. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 299. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 300. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2032 (USD MILLION)
TABLE 301. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 302. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 303. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 304. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 305. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 306. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 307. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2032 (USD MILLION)
TABLE 308. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 309. BRICS CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2032 (USD MILLION)
TABLE 310. BRICS CANCER IM

Companies Mentioned

The key companies profiled in this Cancer Imaging System market report include:
  • Agfa-Gevaert N.V.
  • Agilent Technologies Inc.
  • Analogic Corporation
  • Barco NV
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Bracco Imaging S.p.A.
  • Canon Medical Systems Corporation
  • Carestream Health Inc.
  • Danaher Corporation
  • Delphinus Medical Technologies Inc.
  • Elekta AB
  • Esaote S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hologic Inc.
  • IBA Ion Beam Applications SA
  • Illumina Inc.
  • Konica Minolta Inc.
  • Koninklijke Philips N.V.
  • Lantheus Holdings Inc.
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers AG

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 20.07 Billion
Forecasted Market Value ( USD ) by 2032 $ 28.45 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Breast Cancer Imaging Market Size, Share & Trends Analysis Report by Stage of Care (Diagnostic, Monitoring), End Use (Hospitals, Breast Care Centers), Technology and Region with Growth Forecasts, 2025-2033 - Product Image

Breast Cancer Imaging Market Size, Share & Trends Analysis Report by Stage of Care (Diagnostic, Monitoring), End Use (Hospitals, Breast Care Centers), Technology and Region with Growth Forecasts, 2025-2033

  • Report
  • 140 Pages
  • Global
From
Next-Generation Oncology Devices & Solutions Market - Global Forecast 2026-2032 - Product Image

Next-Generation Oncology Devices & Solutions Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Radiology as a Service Market - Global Forecast 2026-2032 - Product Image

Radiology as a Service Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Nuclear Imaging Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Nuclear Imaging Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Molecular Imaging Market Size, Share, & Trends Analysis Report by Modality (Molecular Ultrasound Imaging, Positron Emission Tomography), Application (Cardiovascular, Neurology), End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Molecular Imaging Market Size, Share, & Trends Analysis Report by Modality (Molecular Ultrasound Imaging, Positron Emission Tomography), Application (Cardiovascular, Neurology), End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From

About the Cancer Imaging System Market

The Cancer Imaging System market is a subset of the Medical Imaging market, which is used to diagnose and treat diseases. It is composed of a variety of imaging technologies, such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and positron emission tomography (PET). These technologies are used to detect and monitor cancer, as well as to plan and evaluate treatments. Cancer Imaging Systems are used to detect and diagnose cancer, as well as to monitor the progress of treatment. They can also be used to detect and monitor metastases, or the spread of cancer to other parts of the body. Some companies in the Cancer Imaging System market include GE Healthcare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems, Hitachi Medical Systems, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.